Laddar...
Engineered AXL(−ECD)-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration
AXL receptor tyrosine kinase ligand (AXL), a tyrosine kinase receptor that is commonly overexpressed in numerous types of cancer, significantly promotes drug resistance and metastasis in tumor cells. Inhibition of the AXL/growth arrest-specific 6 (Gas6) signaling pathway is emerging as a potential a...
Sparad:
| I publikationen: | Oncol Lett |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507473/ https://ncbi.nlm.nih.gov/pubmed/31186805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10255 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|